Carlsmed (CARL) Payables (2024 - 2026)

Carlsmed (CARL) has 3 years of Payables data on file, last reported at $3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Payables changed N/A year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (changed N/A YoY), and the FY2025 full-year result was $4.5 million, up 85.78% from the prior year.
• Payables for Q1 2026 stood at $3.0 million, down from $4.5 million in the prior quarter.
• Across five years, Payables topped out at $4.5 million in Q4 2025 and bottomed at $2.4 million in Q4 2024.
• The 3-year median for Payables is $2.7 million (2025), against an average of $3.0 million.
• Peak annual rise in Payables reached 85.78% in 2025, while the deepest fall reached 85.78% in 2025.
• A 3-year view of Payables shows it stood at $2.4 million in 2024, then surged by 85.78% to $4.5 million in 2025, then tumbled by 34.12% to $3.0 million in 2026.
• The last three Payables figures came in at $3.0 million (Q1 2026), $4.5 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.

Peer Comparison